News Conference News ACC 2012 Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial L.A. McKeown March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 Stem Cell Therapy Fails to Show Benefit in Chronic Ischemic Heart Failure L.A. McKeown March 24, 2012
News Conference News ACC 2012 Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel Jason Kahn March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Conference News TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip Shelley Wood April 10, 2001